LOQTEQ® Antibacterial Implants
Implant-Associated Infection Prevention
Development/RegulatoryCE & FDA approval in progress
Key Facts
Indication
Implant-Associated Infection Prevention
Phase
Development/Regulatory
Status
CE & FDA approval in progress
Company
About aap Implantate
aap Implantate AG is a publicly traded, Berlin-based pure player in trauma surgery with a mission to make trauma treatment better and more cost-effective. The company has successfully commercialized its patented LOQTEQ® locking compression technology, building a comprehensive anatomical plate and screw system that covers over 95% of relevant indications in extremities. Its strategic focus is now on leveraging this foundation to develop and commercialize two high-potential, next-generation platform technologies: antibacterial silver-coated implants and resorbable magnesium implants, aiming to address the significant surgical challenges of infection and implant removal.
View full company profileTherapeutic Areas
Other Implant-Associated Infection Prevention Drugs
| Drug | Company | Phase |
|---|---|---|
| Programmable Antimicrobial Silver Oxide | Implant Surfaces | Pre-clinical |